Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics
- Conditions
- Asthma
- Registration Number
- NCT00112411
- Lead Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Brief Summary
This study is designed to evaluate the single-dose effectiveness of two bronchodilator inhalers given at two dose levels in pediatric asthma patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
- Persistent asthma for a minimum of six months duration that has been stable for at least four weeks
- Predicted FEV1 60-90%
- Demonstration of 12% airway reversibility
- Continuous requirement for beta-blockers, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, anticholinergics and/or steroids other than those inhaled;
- Presence of clinically-significant non-asthmatic acute or chronic disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (9)
University of Louisville
🇺🇸Louisville, Kentucky, United States
North Carolina Clinical Research
🇺🇸Raleigh, North Carolina, United States
Allergy Associates Medical Group, Inc.
🇺🇸San Diego, California, United States
Aeroallergy Research Labs of Savannah, Inc.
🇺🇸Savannah, Georgia, United States
Mississippi Asthma and Allergy Clinic
🇺🇸Jackson, Mississippi, United States
Northeast Medical Research Associates, Inc.
🇺🇸North Dartmouth, Massachusetts, United States
Allergy and Asthma Research Group
🇺🇸Eugene, Oregon, United States
Allergy Associates Research Center
🇺🇸Portland, Oregon, United States
Medical Research Network
🇺🇸The Woodlands, Texas, United States